Antibacterials
Atovaquone

Atovaquone

Atovaquone, CAS: 95233-18-4, A second-line treatment for Pneumocystis carinii pneumonia (PCP) associated with AIDS. It also has anti-pneumocystis properties.

Introduction

Product Name:

Atovaquone

Product Number:

MB1393
CAS No. :95233-18-4

Molecular Formula:

C₂₂H₁₉ClO₃

Molecular Weight:

366.837
Appearance:Yellow to orange crystalline solid (crystallized from acetonitrile)
MDLMFCD00889188

Fusing Point

216–219°C
Boiling Point542.2±50.0°C(760 mmHg)

Storage Condition

Store frozen at -20°C, keep container tightly closed and away from oxidizing agents.
Chemical StabilityGenerally stable, but need to avoid exposure to oxidizing agents; may decompose at high temperatures or by combustion to produce toxic gases (e.g., carbon monoxide, hydrogen chloride)

Safety Statement

Code (Europe): R50/53 (toxic to aquatic organisms, may cause long term effects in the aquatic environment)

Safety Instructions (Europe): S22 (avoid breathing dust), S24/25 (avoid contact with skin and eyes)

Hazard Class Code

H410/H400/H315/H335/H319/H413

MSDS&COA
Apply

Antiparasitic drugs for the treatment of AIDS-related Pneumocystis carinii pneumonia (PCP), especially for mild to moderate patients refractory to standard therapies (e.g., methotrexate-sulfamethoxazole)


Inquiry